Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients
Dirk P. van Asseldonk(Noordwest Ziekenhuisgroep), Adriaan A. van Bodegraven(Zuyderland Medisch Centrum), Birgit I. Lissenberg‐Witte(OLVG), Joanne Verheij, Carin M. van Nieuwkerk(Amsterdam UMC Location Vrije Universiteit Amsterdam), Melek Simsek(Vrije Universiteit Amsterdam), Dik B. Westerveld(Isala), Chris J. Mulder(Amsterdam University Medical Centers), Bindia Jharap(Meander Medisch Centrum), G. den Hartog(Rijnstate Hospital), Marco C. Becx(St. Antonius Ziekenhuis), Nanne K.H. de Boer, Maurice G. Rüssel(Medisch Spectrum Twente), Elisabeth Bloemena(Amsterdam Neuroscience)
Cited by 11
Related Papers
European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten‐related disorders
|United European Gastroenterology Journal|2019|987
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|715
Newly identified genetic risk variants for celiac disease related to the immune response
|Nature Genetics|2008|690